Translate:
Sign Up
TwitterFacebookLinkedin
Search
  • Dr. Brian Koffman’s Blog
More Links
CLL SocietyCLL Society
CLL Society
Patients and providers fighting CLL together
Smart Patients Get Smart Care™
Donate to CLL Society
  • Home
  • Basics
    • Basic Terms
    • Getting Started
    • Testing
      • Diagnostic Testing
      • Test Before Treat™
      • MRD & Disease Monitoring
    • Early Care
    • Treatment
    • Cake of Cure for CLL
    • CLL Comic Book
    • CLL FAQs
  • Beyond The Basics
    • CLL Overview by Dr. Kipps
    • Richter’s Transformation
    • CAR-T and Other Cellular Therapies
    • Treatment
    • What About CT Scans?
    • How is Treatment Selected?
    • Advanced Prognostics
  • Living Well With CLL
    • Survey Central
      • CLL Society Surveys
      • Paid Research Opportunities
      • Other Surveys
    • Becoming Informed
    • Caregivers
    • Financial Assistance
    • Impact of Diagnosis
    • Planning Ahead
    • Support
    • Taking Charge
  • Clinical Trials
    • The Basics
    • The Patient Perspective
    • News about Clinical Trials
  • Conference Coverage
    • 2020 Conferences
    • 2019 Conferences
    • 2018 Conferences
    • Past Years
      • 2017 Conferences
      • 2016 Conferences
      • 2015 Conferences
      • 2014 Conferences
      • 2013 Conferences
    • Links To Blog Conference Coverage
  • CAR-T
  • Support Groups/Education
    • CLL Support Groups
    • Support Group Calendar
    • CLL Bloodline Monthly Support Group Newsletter
    • CLL Society Patient & Caregiver Educational Forums
    • Upcoming CLL Patient Education Programs
    • On Demand Education
    • Leader Resources
  • News
    • CLL Society in the News
    • The CLL Society Tribune
      • The CLL Society Tribune Index
      • Ask & Tell
      • Ask The Doctor
      • Ask The Lab Scientist
      • Ask the Hospice/Palliative Care Doctor
      • Ask The Pharmacist
      • Did You Know?
    • Business, Finances, Insurance & Regulatory
    • Official Statements and Press Releases
    • Publications and Research
    • Clinical
    • CLL Society Alerts
  • About Us
    • Contact
    • Mission & Vision
    • Board of Directors
    • Medical Advisory Board
    • Patient Advisory Board
    • The CLL Society Staff
    • The Orange County CLL Support Group
    • Volunteer With Us!
Menu back  

Category Archives: News

You are here:
  1. Home
  2. Category "News"
  3. (Page 18)

Approval of Obinutuzumab (O) or Gazyva in Combination with Chlorambucil (C) for Untreated CLL Patients with Other Co-morbidities in Quebec, England and Wales

Take Away Points: Obinutuzumab (O) has been approved for use in combination with chlorambucil (C) for untreated CLL patients with other...
June 12, 2015Business, Finances, Insurance & RegulatoryBy Todd Dennison

Phase III RESONATE-2 That Compared Ibrutinib To Chlorambucil In > 65 Year Old Treatment Naïve Patients Excluding Those With Deletion 17p

Take Away Points: Ibrutinib is superior to chlorambucil for frontline therapy in those treatment naïve patients >65 without deletion 17p. This could...
June 10, 2015ClinicalBy Todd Dennison

ASCO 2015: Follow-up on a Phase Ib Trial of Idelalisib in Combination with Chemoimmunotherapy in Chronic Lymphocytic Leukemia

This is one of the few abstracts (#7011) on CLL at the 2015 American Society Clinical Oncology (ASCO) Annual meeting...
May 29, 2015NewsBy Todd Dennison

AbbVie Finalizes Acquisition of Pharmacyclics

It’s Official AbbVie has completed its $21 billion buyout of Pharmacyclics. AbbVie, a global biopharmaceutical company, announced today that it has completed...
May 27, 2015Business, Finances, Insurance & Regulatory, NewsBy Todd Dennison

ASH 2014: Dr. Adrian Wiestner Reviews Data on Novel Oral Therapies for CLL

In an interview with Dr. Adrian Weistner from the National Institutes of Health in Bethesda, MD, we discussed the latest data on...
May 25, 20152014 Conferences, NewsBy Todd Dennison

Investigational Medicine Venetoclax (ABT-199) Receives Breakthrough Therapy Designation In Relapsed Or Refractory Chronic Lymphocytic Leukemia (CLL) In Previously Treated Patients With The 17p Deletion Genetic Mutation

This is very good news for my fellow CLL patients with 17p deletion. It means that venetoclax, better known to...
May 7, 2015Business, Finances, Insurance & Regulatory, NewsBy Todd Dennison

The Addition Of Ibrutinib To BR (Bendamustine-Rituximab) Improves Progression-Free Survival (PFS)

Patients in the BR arm are allowed to crossover While this press release from Pharmacyclics broadens the potential role of ibrutinib...
March 26, 2015Leave a commentClinicalBy clladm1n

NCCN Guidelines On CLL To Shift Toward Targeted Therapies

Dr. Bill Wierda was interviewed by Medscape about possible coming shift in the CLL guidelines developed by the NCCN. The...
March 26, 2015Leave a commentClinicalBy clladm1n

Clonal Heterogeneity In CLL: Part 1

Take Away Points: Cancer by its nature is genomic unstable. Over time it acquires more mutations. New clones and sub-clones can arise over...
March 26, 20155 CommentsClinicalBy clladm1n

Clonal Heterogeneity In CLL: Part 2

Take Away Points: CLL evolves drastically over time, but the seeds of the population that leads to resistance and relapse may...
March 26, 20154 CommentsClinicalBy clladm1n
1
234567891011121314
…1516171819
Prev pageNext page
  • Home
  • Basics
    • Basic Terms
    • Getting Started
    • Testing
      • Diagnostic Testing
      • Test Before Treat™
      • MRD & Disease Monitoring
    • Early Care
    • Treatment
    • Cake of Cure for CLL
    • CLL Comic Book
    • CLL FAQs
  • Beyond The Basics
    • CLL Overview by Dr. Kipps
    • Richter’s Transformation
    • CAR-T and Other Cellular Therapies
    • Treatment
    • What About CT Scans?
    • How is Treatment Selected?
    • Advanced Prognostics
  • Living Well With CLL
    • Survey Central
      • CLL Society Surveys
      • Paid Research Opportunities
      • Other Surveys
    • Becoming Informed
    • Caregivers
    • Financial Assistance
    • Impact of Diagnosis
    • Planning Ahead
    • Support
    • Taking Charge
  • Clinical Trials
    • The Basics
    • The Patient Perspective
    • News about Clinical Trials
  • Conference Coverage
    • 2020 Conferences
    • 2019 Conferences
    • 2018 Conferences
    • Past Years
      • 2017 Conferences
      • 2016 Conferences
      • 2015 Conferences
      • 2014 Conferences
      • 2013 Conferences
    • Links To Blog Conference Coverage
  • CAR-T
  • Support Groups/Education
    • CLL Support Groups
    • Support Group Calendar
    • CLL Bloodline Monthly Support Group Newsletter
    • CLL Society Patient & Caregiver Educational Forums
    • Upcoming CLL Patient Education Programs
    • On Demand Education
    • Leader Resources
  • News
    • CLL Society in the News
    • The CLL Society Tribune
      • The CLL Society Tribune Index
      • Ask & Tell
      • Ask The Doctor
      • Ask The Lab Scientist
      • Ask the Hospice/Palliative Care Doctor
      • Ask The Pharmacist
      • Did You Know?
    • Business, Finances, Insurance & Regulatory
    • Official Statements and Press Releases
    • Publications and Research
    • Clinical
    • CLL Society Alerts
  • About Us
    • Contact
    • Mission & Vision
    • Board of Directors
    • Medical Advisory Board
    • Patient Advisory Board
    • The CLL Society Staff
    • The Orange County CLL Support Group
    • Volunteer With Us!
Navigation
2021 Industry Advisory Council

Copyright 2021 CLL Society, Inc. All Rights Reserved.
Terms & Conditions | Privacy Policy





This site uses cookies: Find out more.